Abstract: Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.

Abstract: Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.

Abstract: Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.

Abstract: A system and method for incremental do-not-disturb. User input is received to activate the incremental do-not-disturb on a telephone. The incremental do-not-disturb is activated for a time period in response to receiving the user input to activate the incremental do-not-disturb. Incoming calls are diverted during the time period in response to activating the incremental do-not-disturb.

Abstract: An ear-level hearing device and a handheld computer with a graphical user interface determines a subject's own hearing threshold. Hardware includes the smartphone, viewing screen of the smartphone, smartphone software, ear level hearing device, transmitter on the smartphone and receiver on the ear level device (ELD) communicating with the graphical user interface on the smartphone to the ear level hearing device. The interface on the smartphone may include an automatic routine or buttons to vary frequency and amplitude of a frequency dependent sound presentation to the earpiece. Software installed on the hand-held smartphone system sends wireless signals to the ELD changing acoustic parameters in the listening device. The ELD stores frequency/amplitude parameters of the thresholds and wirelessly delivers them to the smartphone. The smartphone uses the threshold data to derive the appropriate amplified acoustical signal (relative to the thresholds) to the subject.

Abstract: A latch assembly is provided for latching a pluggable electronic module to a receptacle assembly. The latch assembly includes a yoke assembly having an actuation end that is movable between a latched position and an unlatched position. A lever is operatively connected to the yoke assembly to move the actuation end of the yoke assembly between the latched and unlatched positions. A latch element is operatively connected to the actuation end of the yoke assembly. The latch element is movable along a latch axis between an extended position and a retracted position as the actuation end is moved between the latched and unlatched positions, respectively. The actuation end of the yoke assembly is configured to float along the latch axis relative to the latch element.

Abstract: Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.

Abstract: A latch assembly is provided for latching a pluggable electronic module to a receptacle assembly. The latch assembly includes a yoke assembly having an actuation end that is movable between a latched position and an unlatched position. A lever is operatively connected to the yoke assembly to move the actuation end of the yoke assembly between the latched and unlatched positions. A latch element is operatively connected to the actuation end of the yoke assembly. The latch element is movable along a latch axis between an extended position and a retracted position as the actuation end is moved between the latched and unlatched positions, respectively. The actuation end of the yoke assembly is configured to float along the latch axis relative to the latch element.

Abstract: Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.

Abstract: A cage is provided for a receptacle assembly that includes a receptacle connector. The cage includes an electrically conductive body comprising an upper wall, a lower wall, and side walls that extend from the upper wall to the lower wall. The body has a front end and an internal compartment. The front end is open to the internal compartment of the body. The internal compartment is configured to hold the receptacle connector therein. The internal compartment is configured to receive a pluggable module therein through the front end. A connector cover is integrally formed with the lower wall of the body. The connector cover extends within the internal compartment of the body. The connector cover includes an interior chamber that is configured to hold the receptacle connector therein such that the cover extends over at least a portion of the receptacle connector.

Abstract: Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.

Abstract: Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.

Abstract: Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.

Abstract: A straddle mount connector is provided for edge mounting to a circuit board of a pluggable module. The straddle mount connector includes a dielectric connector body having a base and a plug extending from the base. The base is configured to be coupled to an edge of the circuit board. The plug has opposite first and second sides and a plate cavity that extends within the plug between the first and second sides. The plug is configured to be received within a receptacle of a receptacle connector. Electrical contacts are held by the connector body. The electrical contacts include mating segments. The mating segments of a first group of the electrical contacts are arranged in a first row that extends a length along the first side of the plug. The mating segments of a second group of the electrical contacts are arranged in a second row that extends a length along the second side of the plug. A ground plate is held within the plate cavity of the plug of the connector body.

Abstract: A receptacle connector includes a dielectric connector body having a receptacle configured to receive a mating connector therein. Signal and ground contacts are held by the connector body. The signal and ground contacts include mating segments that are arranged within the receptacle of the connector body in a row that extends a length along a row axis. The mating segments of the signal and ground contacts include mating interfaces that extend within the receptacle for mating with corresponding mating contacts of the mating connector. A ground shield extends within the receptacle. The ground shield overlaps the mating segments of the signal and ground contacts within the receptacle along the length of the row of the mating segments.

Abstract: A straddle mount connector is provided for edge mounting to a circuit board of a pluggable module. The straddle mount connector includes a dielectric connector body having a base and a plug extending from the base. The base is configured to be coupled to an edge of the circuit board. The plug has opposite first and second sides and a plate cavity that extends within the plug between the first and second sides. The plug is configured to be received within a receptacle of a receptacle connector. Electrical contacts are held by the connector body. The electrical contacts include mating segments. The mating segments of a first group of the electrical contacts are arranged in a first row that extends a length along the first side of the plug. The mating segments of a second group of the electrical contacts are arranged in a second row that extends a length along the second side of the plug. A ground plate is held within the plate cavity of the plug of the connector body.

Abstract: A system and method for incremental do-not-disturb. User input is received to activate the incremental do-not-disturb. The incremental do-not-disturb is activated for a time period in response to receiving the user input to activate the incremental do-not-disturb. The incoming calls are diverted during the time period in response to activating the incremental do-not-disturb.

Abstract: Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.

Abstract: Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.

Abstract: A latch assembly for a connector is provided. The latch assembly includes a latch coupled to the connector. The latch includes a crossbar and a latch arm extending from the crossbar. The latch arm is configured to engage a mating connector. An anchor point engages the latch. The latch rotates about the anchor point between an open position, where the latch arm is configured to disengage from the mating connector, and a closed position. where the latch arm is configured to engage the mating connector. A biasing mechanism engages the crossbar of the latch to bias the latch into the closed position, wherein in the closed position the latch assembly generates a latch force on the mating connector in a direction opposite to a load force imposed on at least one of the connector and the mating connector.